Literature DB >> 19115028

Do tumor cavitation and sex in resected stage I non-small-cell lung cancer correlate with prognosis?

Meng Wang1, Jing Zhao, Yi Pan, Yan-Jun Su, Jian You, Xiao-Liang Zhao, Chang-Li Wang.   

Abstract

BACKGROUND: Multiple factors have been reported as affecting the prognosis, and they affect the therapeutic outcomes of stage I non-small-cell lung cancer (NSCLC) patients. Most studies focus on patients receiving combined-modality therapy, whereas there are few studies that focus on patients undergoing surgery alone. The aim of this study was to identify risk factors for disease relapse and unfavorable prognosis in stage I NSCLC patients treated with surgery alone.
METHODS: A total of 315 stage I NSCLC patients who were treated with surgery alone as the definitive therapy were identified. Risk factors for disease relapse and unfavorable prognosis were estimated by univariate and multivariate analyses.
RESULTS: Sex, tumor pathologic stage, and cavitating lung cancer were identified as independent risk factors for relapse and overall survival using the multivariate analysis. Sex, tumor pathologic stage, and cavitating lung cancer were identified as independent risk factors for early relapse, and sex and cavitating lung cancer were independent risk factors for late relapse.
CONCLUSION: Tumor cavitation, pathologic stage IB, and being male are predictors of poor outcome for patients with stage I NSCLC who undergo resection.

Entities:  

Mesh:

Year:  2009        PMID: 19115028     DOI: 10.1007/s00268-008-9859-3

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  37 in total

1.  Smoking affects treatment outcome in patients with advanced nonsmall cell lung cancer.

Authors:  Anne S Tsao; Diane Liu; J Jack Lee; Margaret Spitz; Waun Ki Hong
Journal:  Cancer       Date:  2006-06-01       Impact factor: 6.860

2.  Tumor cavitation in stage I non-small cell lung cancer: epidermal growth factor receptor expression and prediction of poor outcome.

Authors:  Amir Onn; Du Hwan Choe; Roy S Herbst; Arlene M Correa; Reginald F Munden; Mylene T Truong; Ara A Vaporciyan; Takeshi Isobe; Michael Z Gilcrease; Edith M Marom
Journal:  Radiology       Date:  2005-10       Impact factor: 11.105

3.  Primary pulmonary cavitating carcinomas.

Authors:  M R Chaudhuri
Journal:  Thorax       Date:  1973-05       Impact factor: 9.139

4.  Cavitary carcinomatosis of the lungs. Report of a case.

Authors:  M Berger; J R Thompson
Journal:  Dis Chest       Date:  1967-07

5.  Influence of sex on lung cancer histology, stage, and survival in a midwestern United States tumor registry.

Authors:  Geoffrey Ringer; J Michael Smith; Amy M Engel; Mary Pat Hendy; Janet Lang
Journal:  Clin Lung Cancer       Date:  2005-11       Impact factor: 4.785

Review 6.  Survival in early-stage non-small cell lung cancer.

Authors:  J C Nesbitt; J B Putnam; G L Walsh; J A Roth; C F Mountain
Journal:  Ann Thorac Surg       Date:  1995-08       Impact factor: 4.330

7.  Should cavitated bronchopulmonary cancers be considered a separate entity?

Authors:  J Mouroux; B Padovani; D Elkaïm; H Richelme
Journal:  Ann Thorac Surg       Date:  1996-02       Impact factor: 4.330

8.  Small adenocarcinoma of the lung. Histologic characteristics and prognosis.

Authors:  M Noguchi; A Morikawa; M Kawasaki; Y Matsuno; T Yamada; S Hirohashi; H Kondo; Y Shimosato
Journal:  Cancer       Date:  1995-06-15       Impact factor: 6.860

9.  Randomized phase II trial comparing bevacizumab plus carboplatin and paclitaxel with carboplatin and paclitaxel alone in previously untreated locally advanced or metastatic non-small-cell lung cancer.

Authors:  David H Johnson; Louis Fehrenbacher; William F Novotny; Roy S Herbst; John J Nemunaitis; David M Jablons; Corey J Langer; Russell F DeVore; Jacques Gaudreault; Lisa A Damico; Eric Holmgren; Fairooz Kabbinavar
Journal:  J Clin Oncol       Date:  2004-06-01       Impact factor: 44.544

Review 10.  Epidermal growth factor receptor inhibition in cancer therapy: biology, rationale and preliminary clinical results.

Authors:  S M Huang; P M Harari
Journal:  Invest New Drugs       Date:  1999       Impact factor: 3.651

View more
  4 in total

1.  Tumor cavitation among lung cancer patients receiving first-line chemotherapy at a tertiary care centre in India: association with histology and overall survival.

Authors:  Navneet Singh; Vamsi Krishna Mootha; Karan Madan; Ashutosh N Aggarwal; Digambar Behera
Journal:  Med Oncol       Date:  2013-05-15       Impact factor: 3.064

Review 2.  [Progress of Postoperative Adjuvant Chemotherapy in Stage I Non-small Cell Lung Cancer].

Authors:  Bo Liu; Fengxia Ding; Shuangqiang Yang
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2015-06

3.  Cavity Formation is a Prognostic Indicator for Pathologic Stage I Invasive Lung Adenocarcinoma of ≥3 cm in Size.

Authors:  Chunji Chen; Shijie Fu; Qiming Ni; Wang Yiyang; Xufeng Pan; Jiao Jing; Heng Zhao; Wang Rui
Journal:  Med Sci Monit       Date:  2019-11-27

4.  Are there radiographic, metabolic, and prognostic differences between cavitary and noncavitary nonsmall cell lung carcinoma? A retrospective fluorodeoxyglucose positron emission tomography/computed tomography study.

Authors:  Nghi C Nguyen; Kumar Abhishek; Samuel Nyon; Hussein Rabie S Farghaly; Medhat M Osman; Hans-Joachim Reimers
Journal:  Ann Thorac Med       Date:  2016 Jan-Mar       Impact factor: 2.219

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.